Elite Pharmaceuticals Inc
OTC:ELTP

Watchlist Manager
Elite Pharmaceuticals Inc Logo
Elite Pharmaceuticals Inc
OTC:ELTP
Watchlist
Price: 0.5601 USD 0.02% Market Closed
Market Cap: 598.4m USD

Intrinsic Value

The intrinsic value of one ELTP stock under the Base Case scenario is 0.2767 USD. Compared to the current market price of 0.5601 USD, Elite Pharmaceuticals Inc is Overvalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ELTP Intrinsic Value
0.2767 USD
Overvaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Elite Pharmaceuticals Inc

What is Valuation History?
Compare ELTP to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ELTP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Elite Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Elite Pharmaceuticals Inc

Current Assets 57.7m
Cash & Short-Term Investments 11.3m
Receivables 29.2m
Other Current Assets 17.2m
Non-Current Assets 38.6m
Long-Term Investments 92k
PP&E 14.1m
Intangibles 5.6m
Other Non-Current Assets 18.8m
Efficiency

Free Cash Flow Analysis
Elite Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Elite Pharmaceuticals Inc

Revenue
84m USD
Cost of Revenue
-44m USD
Gross Profit
40.1m USD
Operating Expenses
-18.9m USD
Operating Income
21.2m USD
Other Expenses
-25.5m USD
Net Income
-4.3m USD
Fundamental Scores

ELTP Profitability Score
Profitability Due Diligence

Elite Pharmaceuticals Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROIC is Increasing
Positive 3Y Average ROE
65/100
Profitability
Score

Elite Pharmaceuticals Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

ELTP Solvency Score
Solvency Due Diligence

Elite Pharmaceuticals Inc's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Low D/E
89/100
Solvency
Score

Elite Pharmaceuticals Inc's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ELTP Price Targets Summary
Elite Pharmaceuticals Inc

There are no price targets for ELTP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Elite Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ELTP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ELTP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ELTP stock?

The intrinsic value of one ELTP stock under the Base Case scenario is 0.2767 USD.

Is ELTP stock undervalued or overvalued?

Compared to the current market price of 0.5601 USD, Elite Pharmaceuticals Inc is Overvalued by 51%.

Back to Top